Aviva Systems Appoints COOTuesday, June 6, 2017
San Diego-based antibody manufacturer Aviva Systems Biology Corp. has hired Yi-Chun "James" Wang as its chief operating officer.
Wang is tasked with developing new products and with expanding the service division of GenWay Biotech, a San Diego-based protein manufacturer ASB acquired in February.
"With ASB's recent acquisition of GenWay Biotech, I believe the company is positioned to be a leader in protein research, assay development and GMP/CLIA laboratory services," he said.
Wang, who has 17 years experience in the life science proteomics market, was most recently COO of Irvine-based biotech company GeneTex Inc., where he helped grow the company's antibody business and expand the company's global appearance, managed strategic initiatives and oversaw research, new product development and production, ASB said.